title: The FDA revises requirements for levothyroxine products.
authors.affiliation: Georgetown University, Washington, DC, USA.
authors.forename: Kenneth
authors.initials: K
authors.lastname: Burman
authors.forename: James
authors.initials: J
authors.lastname: Hennessey
authors.forename: Michael
authors.initials: M
authors.lastname: McDermott
authors.forename: Leonard
authors.initials: L
authors.lastname: Wartofsky
authors.forename: Charles
authors.initials: C
authors.lastname: Emerson
mesh_terms: D002626:Chemistry, Pharmaceutical / Q000592:standards*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004355:Drug Stability; D004356:Drug Storage; D006801:Humans; D013974:Thyroxine; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D013974:Thyroxine